Q32 Bio, Inc. (QTTB)
16.36
+0.39
(+2.44%)
USD |
NASDAQ |
Aug 24, 16:00
16.34
-0.02
(-0.12%)
After-Hours: 20:00
Q32 Bio 1 Year Total Returns (Daily) : 756.5% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 756.5% |
| August 21, 2026 | 751.7% |
| August 20, 2026 | 757.3% |
| August 19, 2026 | 775.1% |
| August 18, 2026 | 649.5% |
| August 17, 2026 | 709.6% |
| August 14, 2026 | 705.9% |
| August 13, 2026 | 749.2% |
| August 12, 2026 | 814.9% |
| August 11, 2026 | 760.9% |
| August 10, 2026 | 861.3% |
| August 07, 2026 | 771.5% |
| August 06, 2026 | 730.8% |
| August 05, 2026 | 732.8% |
| August 04, 2026 | 737.0% |
| August 03, 2026 | 658.2% |
| July 31, 2026 | 606.3% |
| July 30, 2026 | 651.7% |
| July 29, 2026 | 590.6% |
| July 28, 2026 | 604.5% |
| July 27, 2026 | 588.2% |
| July 24, 2026 | 555.8% |
| July 23, 2026 | 557.3% |
| July 22, 2026 | 573.2% |
| July 21, 2026 | 606.9% |
| Date | Value |
|---|---|
| July 20, 2026 | 585.2% |
| July 17, 2026 | 548.7% |
| July 16, 2026 | 447.1% |
| July 15, 2026 | 654.8% |
| July 14, 2026 | 809.4% |
| July 13, 2026 | 703.8% |
| July 10, 2026 | 237.7% |
| July 09, 2026 | 733.8% |
| July 08, 2026 | 912.9% |
| July 07, 2026 | 901.5% |
| July 06, 2026 | 793.4% |
| July 02, 2026 | 809.0% |
| July 01, 2026 | 775.0% |
| June 30, 2026 | 755.0% |
| June 29, 2026 | 875.2% |
| June 26, 2026 | 749.7% |
| June 25, 2026 | 666.0% |
| June 24, 2026 | 601.9% |
| June 23, 2026 | 676.5% |
| June 22, 2026 | 716.1% |
| June 18, 2026 | 646.1% |
| June 17, 2026 | 696.9% |
| June 16, 2026 | 658.9% |
| June 15, 2026 | 670.1% |
| June 12, 2026 | 643.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Rallybio Corp. | 235.5% |
| Beam Therapeutics, Inc. | 70.25% |
| C4 Therapeutics, Inc. | 57.09% |
| Arrowhead Pharmaceuticals, Inc. | 306.6% |
| Oncolytics Biotech, Inc. | -16.43% |